Recce Pharmaceuticals to Raise AU$4 million via Share Placement; Shares Down 17%
MT Newswires Live
Jun 26
Recce Pharmaceuticals (ASX:RCE) received firm commitments to raise AU$4 million through the placement of 10 million new shares at AU$0.40 apiece, according to a Friday filing with the Australian bourse.
The company is also launching a share purchase plan to allow eligible shareholders to subscribe for up to AU$30,000 worth of new shares to raise up to a further AU$4 million on the same terms as the placement, the filing said.
Funds will be used to bolster the balance sheet for commercial licensing with a Middle Eastern pharmaceutical firm, and fund clinical trials and Investigational New Drug enabling activities, per the filing.
Shares fell 17% in morning trade on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.